◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksC › CTRE

CareTrust REIT Inc. (CTRE) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · DATA UPDATED 2026-09-19

CareTrust REIT Inc. (CTRE) operates in the REIT - HEALTHCARE FACILITIES industry and is headquartered in Dana Point, United States with about 43 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, CTRE reported $477M in revenue and $321M in net income.

CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties.

Interactive charts & full statements → Open the CTRE valuation workbench →

CTRE Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Total Revenue$468M$477M$228M$199M$188M$190M$176M$159M$155M$131M$104M$74M$59M$49M$42M
Gross Profit$345M$282M$215M$189M$178M$187M$171M$153M$140M$118M$94M$66M$52M$41M$36M
Gross Margin %73.8%59.1%94.1%95.2%95.0%98.1%97.3%96.3%90.4%90.1%90.0%89.4%87.8%85.0%84.4%
Operating Income (EBIT)$288M$320M$124M$116M$104M$104M$102M$85M$82M$57M$52M$34M$18M$13M$13M
Operating Margin %61.6%67.2%54.4%58.4%55.4%54.9%58.0%53.5%52.9%43.8%50.3%46.4%29.8%25.9%30.0%
Net Income$335M$321M$125M$54M($8M)$72M$81M$46M$58M$26M$29M$10M($8M)$0M$0M
Net Margin %71.5%67.3%54.8%27.1%-4.0%37.9%46.0%29.1%37.3%19.7%28.2%13.6%-13.8%-0.8%0.3%
EBITDA$495M$462M$212M$146M$73M$151M$157M$126M$130M$98M$85M$24M$23M$36M$34M
Earnings Per Share (EPS)$1.61$1.57$0.81$0.51$-0.08$0.75$0.85$0.50$0.73$0.36$0.52$0.27$-0.36$-0.02$0.00
Shares Outstanding (M)224M204M155M106M97M96M95M93M79M73M56M37M23M22M22M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTRE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$123M$143M$135M$104M$86M$72M$62M$57M$55M
Gross Profit$81M$80M$102M$83M$69M$59M$52M$53M
Gross Margin %56.9%58.9%97.5%96.5%97.0%94.8%90.2%96.0%
Operating Income (EBIT)$93M$87M$60M$49M$43M$29M$31M$33M
Operating Margin %65.1%64.1%57.1%57.2%59.5%47.0%54.0%59.9%
Net Income$89M$80M$111M$75M$69M$66M$52M$33M$11M
Net Margin %72.4%56.2%82.4%71.8%79.7%91.8%83.8%58.5%19.4%
EBITDA$122M$153M$116M$103M$90M$73M$56M$33M
Earnings Per Share (EPS)$0.38$0.36$0.55$0.35$0.36$0.35$0.29$0.21$0.07
Shares Outstanding (M)224M204M212M193M187M182M160M145M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTRE Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Cash from Operations (CFO)$413M$394M$244M$155M$144M$157M$146M$126M$99M$89M$64M$40M$22M$27M$24M
Capital Expenditures (CapEx)$16M$15M$8M$11M$7M$6M$90M$322M$108M$290M$279M$233M$46M$55M$50M
Free Cash Flow (FCF)$397M$379M$236M$144M$137M$151M$56M($196M)($8M)($201M)($215M)($193M)($24M)($28M)($25M)
FCF Margin %84.8%79.5%103.5%72.4%73.1%79.3%31.9%-123.1%-5.3%-153.6%-206.7%-260.4%-40.3%-57.6%-60.3%
Dividends Paid$280M$259M$172M$115M$106M$101M$93M$81M$63M$53M$37M$22M$33M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTRE Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$135M$90M$121M$101M$101M$71M$75M$67M$53M
Capital Expenditures (CapEx)$4M$3M$5M$3M$5M$2M$4M$3M$1M
Free Cash Flow (FCF)$130M$87M$116M$98M$96M$69M$71M$64M$52M
FCF Margin %105.7%61.1%85.9%93.7%111.9%96.5%114.7%112.6%93.9%
Dividends Paid$75M$75M$67M$63M$54M$50M$45M$41M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CTRE Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Total Assets$5.9B$5.1B$3.4B$2.1B$1.6B$1.6B$1.5B$1.5B$1.3B$1.2B$925M$673M$483M$430M$399M
Cash & Cash Equivalents$48M$198M$214M$294M$13M$20M$19M$20M$37M$7M$8M$11M$25M$1M$1M
Total Liabilities$1.4B$1.1B$508M$666M$771M$725M$589M$591M$524M$590M$473M$411M$369M$268M$214M
Total Debt (Short + Long-Term)$1.2B$894M$397M$1.2B$719M$279M$546M$356M$585M$724M$350M$299M$706M$252M$208M
Total Shareholders' Equity$4.5B$4.0B$2.9B$1.4B$849M$916M$914M$928M$768M$595M$452M$262M$113M$163M$185M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CTRE viewer.

CTRE Metric Deep Dives

Other Companies in REIT - HEALTHCARE FACILITIES

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← CTPNVAll “C” companiesCTRI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.